Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Trial of Ablative MRI-guided Stereotactic Body Radiation Therapy and Tumor Treating Fields for Locally Advanced Pancreas Cancer

NCT05679674 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT05679674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Trial of Ablative MRI-guided Stereotactic Body Radiation Therapy and Tumor Treating Fields for Locally Advanced Pancreas Cancer
Lead sponsor
Baptist Health South Florida
Phase
Not applicable
Overall status
Recruiting
Start date
September 21, 2023
Completion date
June 30, 2027
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced, locally advanced pancreatic adenocarcinoma, pancreas cancer